Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-12 Purchase |
2021-11-16 06:05 am |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,212 | $1.6477 | $1,997 | 374,385 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-03 Tax Withholding |
2022-01-04 9:34 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
979 | $1.74 | 338,986 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 9:34 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
28,730 | $1.71 | 338,986 (Direct) |
View |
| 2021-12-15 Tax Withholding |
2021-12-17 7:36 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
5,690 | $1.61 | 368,695 (Direct) |
View |
| 2021-07-08 Tax Withholding |
2021-07-13 06:03 am |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
5,172 | $1.96 | 373,173 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 5:04 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
2,500 | $0 | 378,345 (Direct) |
View |
| 2021-06-07 Tax Withholding |
2021-06-08 5:04 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
719 | $2.3 | 378,345 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-12 6:58 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
5,172 | $3.24 | 376,564 (Direct) |
View |
| 2021-02-03 Tax Withholding |
2021-02-12 4:10 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,075 | $3.74 | 381,736 (Direct) |
View |
| 2021-01-18 Tax Withholding |
2021-01-20 7:56 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,352 | $3.03 | 382,811 (Direct) |
View |
| 2021-01-15 Tax Withholding |
2021-01-20 7:32 pm |
N/A N/A |
Baudax Bio Inc. | BXRX | Lake Ryan David Chief Financial Officer |
26,658 | $1.3 | 152,328 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 7:32 pm |
N/A 2023-01-15 |
Baudax Bio Inc. | BXRX | Lake Ryan David Chief Financial Officer |
108,077 | $0 | 152,328 (Direct) |
View |
| 2021-01-08 Tax Withholding |
2021-01-12 5:18 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
12,610 | $2.99 | 384,163 (Direct) |
View |
| 2021-01-08 Option Award |
2021-01-12 5:18 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
266,000 | $0 | 384,163 (Direct) |
View |
| 2021-01-02 Tax Withholding |
2021-01-05 4:57 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,210 | $3.09 | 130,773 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-18 8:57 pm |
N/A 2030-12-15 |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
195,713 | $0 | 248,488 (Direct) |
View |
| 2020-12-05 Tax Withholding |
2020-12-09 5:45 pm |
N/A N/A |
Baudax Bio Inc. | BXRX | Lake Ryan David Chief Financial Officer |
19,909 | $1.14 | 70,909 (Direct) |
View |
| 2020-12-05 Tax Withholding |
2020-12-09 5:44 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
7,611 | $2.3 | 52,775 (Direct) |
View |
| 2020-06-05 Exercise |
2020-06-09 4:32 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
2,500 | $0 | 62,886 (Direct) |
View |
| 2020-06-05 Tax Withholding |
2020-06-09 4:32 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
852 | $4.95 | 62,886 (Direct) |
View |